Furthermore, qRT-PCR and luciferase analysis also showed that RUNX1 knockdown resulted in the inhibition of androgen-mediated gene and AR transcriptional activity in prostate cancer cells (Fig.3E, F, Supplementary Fig.3). This evidence concerns the gene RUNX1 and prostate cancer.